The Retina in Health and Disease

Dear Colleagues,

Vision is the most important sense in higher mammals. The retina is the first step in visual processing, and the window to the brain. It is not surprising that problems arising in the retina would lead to moderate to severe visual impairments. According to the World Health Organization, 1.2 billion people suffer from visual impairments and blindness. Moreover, people live longer, and many retinal diseases become more frequent. New advances in retina research offer hope to cure many of these illnesses. For example, in recent years, the endocannabinoid system, present in the retina, has become an interesting therapeutic target. Other new approaches (e.g., stem cell therapy) and technological advances (e.g., retinal implants) are underway to cure these diseases. Of course, to understand pathology, one must know about the normal retina. In this issue, we would like to present up-to-date advances on the healthy retina (e.g., anatomy, physiology, molecular biology), as well as common retinal diseases and pharmacological treatments.

Prof. Maurice Ptito
Dr. Joseph Bouskila
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.